These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32665557)

  • 1. Spatial domain analysis predicts risk of colorectal cancer recurrence and infers associated tumor microenvironment networks.
    Uttam S; Stern AM; Sevinsky CJ; Furman S; Pullara F; Spagnolo D; Nguyen L; Gough A; Ginty F; Lansing Taylor D; Chakra Chennubhotla S
    Nat Commun; 2020 Jul; 11(1):3515. PubMed ID: 32665557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
    Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
    Front Immunol; 2020; 11():550250. PubMed ID: 33193316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
    Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
    EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of Osteopontin (SPP1) in colorectal carcinoma requires a personalized molecular approach.
    Assidi M; Gomaa W; Jafri M; Hanbazazh M; Al-Ahwal M; Pushparaj P; Al-Harbi A; Al-Qahtani M; Buhmeida A; Al-Maghrabi J
    Tumour Biol; 2019 Sep; 41(9):1010428319863627. PubMed ID: 31500540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weighted gene coexpression analysis indicates that PLAGL2 and POFUT1 are related to the differential features of proximal and distal colorectal cancer.
    Lv Y; Xie B; Bai B; Shan L; Zheng W; Huang X; Zhu H
    Oncol Rep; 2019 Dec; 42(6):2473-2485. PubMed ID: 31638246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
    Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
    Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
    Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging era of personalized medicine in advanced colorectal cancer.
    Wu CWK; Reid M; Leedham S; Lui RN
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1411-1425. PubMed ID: 35815339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic index based on an eleven gene signature to predict systemic recurrences in colorectal cancer.
    Kim SK; Kim SY; Kim CW; Roh SA; Ha YJ; Lee JL; Heo H; Cho DH; Lee JS; Kim YS; Kim JC
    Exp Mol Med; 2019 Oct; 51(10):1-12. PubMed ID: 31578316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of circular RNAs in colorectal tumor microenvironment.
    Viralippurath Ashraf J; Sasidharan Nair V; Saleh R; Elkord E
    Biomed Pharmacother; 2021 May; 137():111351. PubMed ID: 33550046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients.
    Yang IP; Tsai HL; Miao ZF; Huang CW; Kuo CH; Wu JY; Wang WM; Juo SH; Wang JY
    J Transl Med; 2016 Apr; 14(1):108. PubMed ID: 27126129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profile in patients with stage II colorectal cancer: a Turkish referral center study.
    Tanoglu A; Balta AZ; Berber U; Ozdemir Y; Emirzeoglu L; Sayilir A; Sucullu I
    Asian Pac J Cancer Prev; 2015; 16(5):1851-5. PubMed ID: 25773836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
    Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
    Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
    Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
    World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.